Safety, effectiveness, and usefulness of higher-dose tablets of generic pirfenidone in patients with IPF: a nationwide observational study in South Korea

• Main Authors: Jieun Kang (Author), Kwan Ho Lee (Author), Jae Ha Lee (Author), Yi Yeong Jeong (Author), Sun Mi Choi (Author), Ho Cheol Kim (Author), Joo Hun Park (Author), Hyun-Kyung Lee (Author), Suk Joong Yong (Author), Hye Sook Choi (Author), Hak Ryul Kim (Author), Yangjin Jegal (Author), Won-il Choi (Author), Eun Joo Lee (Author), Jin Woo Song (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

BackgroundPirfenidone is an antifibrotic medication approved for idiopathic pulmonary fibrosis (IPF). Fybro®, a generic version of pirfenidone developed in South Korea, gained approval and is available in 200 mg and in higher-dose formulations of 400 and 600 mg. This real-world prospective cohort st...